{"entity":{"type":"insider","cik":"0001700449","url":"/insider/0001700449","json_url":"/insider/0001700449.json","name":"Arix Bioscience plc","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":7,"first":"2018-10-26","last":"2020-10-05","span_basis":"filed_date"},"name_variants":[{"name":"Arix Bioscience plc","source":"filing","n_filings":7,"first_seen":"2018-10-26","last_seen":"2020-10-05"}],"transactions":[{"id":2208319,"accession":"0000899243-20-027297","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000899243-20-027297","line_url":"/filing/0000899243-20-027297#line-10","is_derivative":false,"issuer_cik":"0001664106","issuer_name":"LogicBio Therapeutics, Inc.","issuer_ticker":"LOGC","issuer_name_source":null,"issuer_url":"/issuer/0001664106","owner_cik":null,"owner_name":"Arix Bioscience Holdings Ltd; Arix Bioscience plc","owner_display_name":"Arix Bioscience Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":273584.0,"shares_display":"273,584","price_per_share":7.5365,"price_display":"7.54","price_state":"stated","total_value":2061865.816,"total_display":"2,061,865.82","total_whole":"2,061,866","shares_owned_after":2381436.0,"shares_owned_after_display":"2,381,436","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-28","filed_date":"2020-10-05","scope":"insider"},{"id":2208313,"accession":"0000899243-20-027297","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-20-027297","line_url":"/filing/0000899243-20-027297#line-9","is_derivative":false,"issuer_cik":"0001664106","issuer_name":"LogicBio Therapeutics, Inc.","issuer_ticker":"LOGC","issuer_name_source":null,"issuer_url":"/issuer/0001664106","owner_cik":null,"owner_name":"Arix Bioscience Holdings Ltd; Arix Bioscience plc","owner_display_name":"Arix Bioscience Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":174219.0,"shares_display":"174,219","price_per_share":7.077,"price_display":"7.08","price_state":"stated","total_value":1232947.863,"total_display":"1,232,947.86","total_whole":"1,232,948","shares_owned_after":2655020.0,"shares_owned_after_display":"2,655,020","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-25","filed_date":"2020-10-05","scope":"insider"},{"id":2208307,"accession":"0000899243-20-027297","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-20-027297","line_url":"/filing/0000899243-20-027297#line-8","is_derivative":false,"issuer_cik":"0001664106","issuer_name":"LogicBio Therapeutics, Inc.","issuer_ticker":"LOGC","issuer_name_source":null,"issuer_url":"/issuer/0001664106","owner_cik":null,"owner_name":"Arix Bioscience Holdings Ltd; Arix Bioscience plc","owner_display_name":"Arix Bioscience Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38514.0,"shares_display":"38,514","price_per_share":7.629,"price_display":"7.63","price_state":"stated","total_value":293823.306,"total_display":"293,823.31","total_whole":"293,823","shares_owned_after":2829239.0,"shares_owned_after_display":"2,829,239","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-24","filed_date":"2020-10-05","scope":"insider"},{"id":2208302,"accession":"0000899243-20-027297","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-20-027297","line_url":"/filing/0000899243-20-027297#line-7","is_derivative":false,"issuer_cik":"0001664106","issuer_name":"LogicBio Therapeutics, Inc.","issuer_ticker":"LOGC","issuer_name_source":null,"issuer_url":"/issuer/0001664106","owner_cik":null,"owner_name":"Arix Bioscience Holdings Ltd; Arix Bioscience plc","owner_display_name":"Arix Bioscience Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":159.0,"shares_display":"159","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":1391.25,"total_display":"1,391.25","total_whole":"1,391","shares_owned_after":2867753.0,"shares_owned_after_display":"2,867,753","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-13","filed_date":"2020-10-05","scope":"insider"},{"id":2208294,"accession":"0000899243-20-027297","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-027297","line_url":"/filing/0000899243-20-027297#line-6","is_derivative":false,"issuer_cik":"0001664106","issuer_name":"LogicBio Therapeutics, Inc.","issuer_ticker":"LOGC","issuer_name_source":null,"issuer_url":"/issuer/0001664106","owner_cik":null,"owner_name":"Arix Bioscience Holdings Ltd; Arix Bioscience plc","owner_display_name":"Arix Bioscience Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1335.0,"shares_display":"1,335","price_per_share":8.79,"price_display":"8.79","price_state":"stated","total_value":11734.65,"total_display":"11,734.65","total_whole":"11,735","shares_owned_after":2867912.0,"shares_owned_after_display":"2,867,912","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-12","filed_date":"2020-10-05","scope":"insider"},{"id":2208288,"accession":"0000899243-20-027297","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-20-027297","line_url":"/filing/0000899243-20-027297#line-5","is_derivative":false,"issuer_cik":"0001664106","issuer_name":"LogicBio Therapeutics, Inc.","issuer_ticker":"LOGC","issuer_name_source":null,"issuer_url":"/issuer/0001664106","owner_cik":null,"owner_name":"Arix Bioscience Holdings Ltd; Arix Bioscience plc","owner_display_name":"Arix Bioscience Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2709.0,"shares_display":"2,709","price_per_share":8.781,"price_display":"8.78","price_state":"stated","total_value":23787.729,"total_display":"23,787.73","total_whole":"23,788","shares_owned_after":2869247.0,"shares_owned_after_display":"2,869,247","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-29","filed_date":"2020-10-05","scope":"insider"},{"id":2208282,"accession":"0000899243-20-027297","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-027297","line_url":"/filing/0000899243-20-027297#line-4","is_derivative":false,"issuer_cik":"0001664106","issuer_name":"LogicBio Therapeutics, Inc.","issuer_ticker":"LOGC","issuer_name_source":null,"issuer_url":"/issuer/0001664106","owner_cik":null,"owner_name":"Arix Bioscience Holdings Ltd; Arix Bioscience plc","owner_display_name":"Arix Bioscience Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22651.0,"shares_display":"22,651","price_per_share":9.004,"price_display":"9.00","price_state":"stated","total_value":203949.604,"total_display":"203,949.60","total_whole":"203,950","shares_owned_after":2871956.0,"shares_owned_after_display":"2,871,956","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-22","filed_date":"2020-10-05","scope":"insider"},{"id":2208278,"accession":"0000899243-20-027297","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-027297","line_url":"/filing/0000899243-20-027297#line-3","is_derivative":false,"issuer_cik":"0001664106","issuer_name":"LogicBio Therapeutics, Inc.","issuer_ticker":"LOGC","issuer_name_source":null,"issuer_url":"/issuer/0001664106","owner_cik":null,"owner_name":"Arix Bioscience Holdings Ltd; Arix Bioscience plc","owner_display_name":"Arix Bioscience Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36983.0,"shares_display":"36,983","price_per_share":9.249,"price_display":"9.25","price_state":"stated","total_value":342055.767,"total_display":"342,055.77","total_whole":"342,056","shares_owned_after":2894607.0,"shares_owned_after_display":"2,894,607","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-20","filed_date":"2020-10-05","scope":"insider"},{"id":2208272,"accession":"0000899243-20-027297","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-027297","line_url":"/filing/0000899243-20-027297#line-2","is_derivative":false,"issuer_cik":"0001664106","issuer_name":"LogicBio Therapeutics, Inc.","issuer_ticker":"LOGC","issuer_name_source":null,"issuer_url":"/issuer/0001664106","owner_cik":null,"owner_name":"Arix Bioscience Holdings Ltd; Arix Bioscience plc","owner_display_name":"Arix Bioscience Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31101.0,"shares_display":"31,101","price_per_share":9.24,"price_display":"9.24","price_state":"stated","total_value":287373.24,"total_display":"287,373.24","total_whole":"287,373","shares_owned_after":2931590.0,"shares_owned_after_display":"2,931,590","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-17","filed_date":"2020-10-05","scope":"insider"},{"id":2208265,"accession":"0000899243-20-027297","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-027297","line_url":"/filing/0000899243-20-027297#line-1","is_derivative":false,"issuer_cik":"0001664106","issuer_name":"LogicBio Therapeutics, Inc.","issuer_ticker":"LOGC","issuer_name_source":null,"issuer_url":"/issuer/0001664106","owner_cik":null,"owner_name":"Arix Bioscience Holdings Ltd; Arix Bioscience plc","owner_display_name":"Arix Bioscience Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16332.0,"shares_display":"16,332","price_per_share":8.559,"price_display":"8.56","price_state":"stated","total_value":139785.588,"total_display":"139,785.59","total_whole":"139,786","shares_owned_after":2962691.0,"shares_owned_after_display":"2,962,691","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-16","filed_date":"2020-10-05","scope":"insider"},{"id":2169113,"accession":"0000899243-20-014559","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-014559","line_url":"/filing/0000899243-20-014559#line-2","is_derivative":false,"issuer_cik":"0001700449","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001700449","owner_cik":null,"owner_name":"Arix Bioscience plc; Arix Bioscience Holdings Ltd","owner_display_name":"Arix Bioscience plc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":366591.0,"shares_display":"366,591","price_per_share":21.3342,"price_display":"21.33","price_state":"stated","total_value":7820925.7122,"total_display":"7,820,925.71","total_whole":"7,820,926","shares_owned_after":2193704.0,"shares_owned_after_display":"2,193,704","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-28","filed_date":"2020-05-29","scope":"insider"},{"id":2169110,"accession":"0000899243-20-014559","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-014559","line_url":"/filing/0000899243-20-014559#line-1","is_derivative":false,"issuer_cik":"0001700449","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001700449","owner_cik":null,"owner_name":"Arix Bioscience plc; Arix Bioscience Holdings Ltd","owner_display_name":"Arix Bioscience plc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12064.0,"shares_display":"12,064","price_per_share":22.3926,"price_display":"22.39","price_state":"stated","total_value":270144.3264,"total_display":"270,144.33","total_whole":"270,144","shares_owned_after":2560295.0,"shares_owned_after_display":"2,560,295","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-27","filed_date":"2020-05-29","scope":"insider"},{"id":3238733,"accession":"0000899243-20-008474","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-008474","line_url":"/filing/0000899243-20-008474#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"IMARA Inc.","issuer_ticker":"IMRA","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":null,"owner_name":"Arix Bioscience plc; Arix Bioscience Holdings Ltd","owner_display_name":"Arix Bioscience plc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187500.0,"shares_display":"187,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":1554558.0,"shares_owned_after_display":"1,554,558","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-16","scope":"insider"},{"id":7775924,"accession":"0000899243-19-029473","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-029473","line_url":"/filing/0000899243-19-029473#line-3","is_derivative":false,"issuer_cik":"0001700449","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001700449","owner_cik":null,"owner_name":"Arix Bioscience plc; Arix Bioscience Holdings Ltd","owner_display_name":"Arix Bioscience plc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12476.0,"shares_display":"12,476","price_per_share":16.8298,"price_display":"16.83","price_state":"stated","total_value":209968.5848,"total_display":"209,968.58","total_whole":"209,969","shares_owned_after":2572359.0,"shares_owned_after_display":"2,572,359","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-17","filed_date":"2019-12-17","scope":"insider"},{"id":7775922,"accession":"0000899243-19-029473","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-029473","line_url":"/filing/0000899243-19-029473#line-2","is_derivative":false,"issuer_cik":"0001700449","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001700449","owner_cik":null,"owner_name":"Arix Bioscience plc; Arix Bioscience Holdings Ltd","owner_display_name":"Arix Bioscience plc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13080.0,"shares_display":"13,080","price_per_share":17.0245,"price_display":"17.02","price_state":"stated","total_value":222680.46,"total_display":"222,680.46","total_whole":"222,680","shares_owned_after":2584835.0,"shares_owned_after_display":"2,584,835","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-16","filed_date":"2019-12-17","scope":"insider"},{"id":7775920,"accession":"0000899243-19-029473","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-029473","line_url":"/filing/0000899243-19-029473#line-1","is_derivative":false,"issuer_cik":"0001700449","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001700449","owner_cik":null,"owner_name":"Arix Bioscience plc; Arix Bioscience Holdings Ltd","owner_display_name":"Arix Bioscience plc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11002.0,"shares_display":"11,002","price_per_share":17.2097,"price_display":"17.21","price_state":"stated","total_value":189341.1194,"total_display":"189,341.12","total_whole":"189,341","shares_owned_after":2597915.0,"shares_owned_after_display":"2,597,915","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-13","filed_date":"2019-12-17","scope":"insider"},{"id":8198168,"accession":"0000899243-19-028848","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-028848","line_url":"/filing/0000899243-19-028848#line-4","is_derivative":false,"issuer_cik":"0001700449","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001700449","owner_cik":null,"owner_name":"Arix Bioscience Holdings Ltd; Arix Bioscience plc","owner_display_name":"Arix Bioscience Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":131696.0,"shares_display":"131,696","price_per_share":16.9103,"price_display":"16.91","price_state":"stated","total_value":2227018.8688,"total_display":"2,227,018.87","total_whole":"2,227,019","shares_owned_after":2608917.0,"shares_owned_after_display":"2,608,917","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-10","scope":"insider"},{"id":8198165,"accession":"0000899243-19-028848","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-028848","line_url":"/filing/0000899243-19-028848","is_derivative":false,"issuer_cik":"0001700449","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001700449","owner_cik":null,"owner_name":"Arix Bioscience Holdings Ltd; Arix Bioscience plc","owner_display_name":"Arix Bioscience Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103754.0,"shares_display":"103,754","price_per_share":18.162629086107522,"price_display":"18.16","price_state":"stated","total_value":1884445.4182,"total_display":"1,884,445.42","total_whole":"1,884,445","shares_owned_after":2740613.0,"shares_owned_after_display":"2,740,613","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-10","scope":"insider","n_lines":2},{"id":8198160,"accession":"0000899243-19-028848","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-028848","line_url":"/filing/0000899243-19-028848#line-1","is_derivative":false,"issuer_cik":"0001700449","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001700449","owner_cik":null,"owner_name":"Arix Bioscience Holdings Ltd; Arix Bioscience plc","owner_display_name":"Arix Bioscience Holdings Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47752.0,"shares_display":"47,752","price_per_share":19.1452,"price_display":"19.15","price_state":"stated","total_value":914221.5904,"total_display":"914,221.59","total_whole":"914,222","shares_owned_after":2844367.0,"shares_owned_after_display":"2,844,367","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-06","filed_date":"2019-12-10","scope":"insider"},{"id":7934399,"accession":"0000899243-19-003683","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-003683","line_url":"/filing/0000899243-19-003683#line-2","is_derivative":false,"issuer_cik":"0001700449","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001700449","owner_cik":null,"owner_name":"Arix Bioscience plc; Arix Bioscience Holdings Ltd","owner_display_name":"Arix Bioscience plc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":428571.0,"shares_display":"428,571","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":5999994.0,"total_display":"5,999,994.00","total_whole":"5,999,994","shares_owned_after":2892119.0,"shares_owned_after_display":"2,892,119","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-12","filed_date":"2019-02-14","scope":"insider"},{"id":6382003,"accession":"0000899243-18-027509","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-027509","line_url":"/filing/0000899243-18-027509#line-2","is_derivative":false,"issuer_cik":"0001664106","issuer_name":"LogicBio Therapeutics, Inc.","issuer_ticker":"LOGC","issuer_name_source":null,"issuer_url":"/issuer/0001664106","owner_cik":null,"owner_name":"Arix Bioscience plc; Arix Bioscience Holdings Ltd","owner_display_name":"Arix Bioscience plc","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700000.0,"shares_display":"700,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":7000000.0,"total_display":"7,000,000.00","total_whole":"7,000,000","shares_owned_after":2979023.0,"shares_owned_after_display":"2,979,023","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-23","filed_date":"2018-10-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001664106","name":"LogicBio Therapeutics, Inc.","url":"/issuer/0001664106","role":"Ten percent owner","n_filings":2,"first_seen":"2018-10-26","last_seen":"2020-10-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001708493","name":"Harpoon Therapeutics, Inc.","url":"/issuer/0001708493","role":"Ten percent owner","n_filings":4,"first_seen":"2019-02-14","last_seen":"2020-05-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001672619","name":"IMARA Inc.","url":"/issuer/0001672619","role":"Ten percent owner","n_filings":1,"first_seen":"2020-03-16","last_seen":"2020-03-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001700449","retrieved_at":"2026-08-22T13:31:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}